Vadzo's Bolt-821CRS is a high-resolution 4K HDR MIPI CSI-2 camera module built on the Onsemi AR0821 HyperLux sensor, delivering embedded HDR exceeding 140 dB, direct SoC integration, and a compact board-level footprint purpose-built for UAV, robotics, medical, and edge AI platforms where USB overhead, power draw, and latency are system-level constraints.
Read More
Accomplished industrial technology sales executive - with senior leadership roles spanning Honeywell, Siemens, Armstrong Fluid Technology, and Johnson Controls - joins ECM to lead the next phase of global commercial growth
Read More
The major upgrade transforms passive note storage into active workflow automation, featuring a redesigned visual interface, seamless integrations, and frontier AI models to maximize professional efficiency.
Read MoreAutomated centralized compliance oversight designed to reduce vendor sprawl and eliminate manual tracking, mid-sized advisory firms find confidence in streamlined IAR CE management with A.D. Banker
Read MoreOndas Sentrycs' Cyber-over-RF Technology to Be Deployed Across Multiple FIFA World Cup Host Venues Across North America for Detection and Mitigation of Unauthorized Drones
Reinforces Sentrycs' Position as a Leading Provider of Non-Disruptive Counter-Drone Solutions for Large-Scale Civilian and Critical Infrastructure Environments
Read MoreNet revenue increase of 5% in Q4 2025 vs. Q3 2025
Jaguar received an up-front payment of $16Mof non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1 - Jaguar's commercialized crofelemer drugs - with an additional $2 million due upon completion of post-closing conditions; and has received $3.0 of up to $20 million in milestone payments and other future payments
Agreement with Future Pak is fully aligned with Jaguar's strategy to concentrate crofelemer development efforts on human rare-disease intestinal failure indications moving forward
Jaguar will appeal Nasdaq's March 5, 2026 noncompliance determination related to Nasdaq Listing Rule 5550(a)(2) at a hearing on April 7, 2026; delisting is stayed pending the panel's final decision
REMINDER: Friday, April 10, Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q4 2025 financials and company updates; Click here to register
Read More
As courts move toward strict product liability for software, LegalMatch.com breaks down why an app's internal engineering could be the latest target for multi-million dollar 'design defect' claims
Read More
